arrow
N

Naoki Fukuda

Kansai Medical University
H指数:17
被引数:1,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study

日本青少年及年轻晚期实体瘤患者中的胚系致病变异:一项全国性肿瘤-正常配对测序研究

2026-07-270
PRE
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

糖皮质激素在粒细胞集落刺激因子相关大血管血管炎中很少需要:日本癌症中心队列

2025-12-010
PRE
NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib

NTRK重排的头颈部软组织肉瘤,其对TRK抑制剂larotrectinib表现出显著反应

2025-12-010
PRE
The first case of GOLGA5-RET fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib

头颈部GOLGA5-RET融合阳性恶性梭形细胞肉瘤对selpercatinib有反应的首例病例。

2025-09-010
PRE
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinib

散发性髓样甲状腺癌伴罕见RET跨膜域突变(A641R),并对塞尔帕卡替尼有反应

2025-09-010
OAAI
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors

自动化和去中心化的血浆游离DNA基因组分析,用于识别晚期实体瘤中的可靶向突变和耐药性改变

2025-05-050
OA
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin

老年营养风险指数作为接受三周顺铂确定性放化疗的局部晚期头颈癌老年患者的预后因素

2023-06-015
PRE